These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24298915)

  • 21. Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
    Gallien S; Taieb F; Schlemmer F; Lagrange-Xelot M; Atlan A; Sarfati C; Molina JM
    Travel Med Infect Dis; 2008 May; 6(3):128-9. PubMed ID: 18486067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
    Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.
    Harel R; Chazan B; Schwartz E
    Am J Trop Med Hyg; 2020 Jun; 102(6):1351-1357. PubMed ID: 32274987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
    Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R
    J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L
    Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Imported malaria in University Hospital Center of Bordeaux, France, 2000-2007. A comparison study with the French national epidemiological data].
    Pistone T; Diallo A; Receveur MC; Mansour R; Roger-Schmeltz J; Millet P; Malvy D
    Bull Soc Pathol Exot; 2010 May; 103(2):104-10. PubMed ID: 20349344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atovaquone/proguanil: the need for family protection.
    Kain KC
    J Travel Med; 2003 May; 10 Suppl 1():S8-12; discussion S21. PubMed ID: 12737754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of atovaquone and proguanil hydrochloride for the prophylaxis of Plasmodium falciparum malaria in South Africa.
    van der Berg JD; Duvenage CS; Roskell NS; Scott TR
    Clin Ther; 1999 Apr; 21(4):741-9. PubMed ID: 10363739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria chemoprophylaxis with atovaquone-proguanil: is a shorter regimen fully protective?
    Grobusch MP
    J Travel Med; 2014; 21(2):79-81. PubMed ID: 24593022
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria surveillance--United States, 2009.
    Mali S; Tan KR; Arguin PM; ;
    MMWR Surveill Summ; 2011 Apr; 60(3):1-15. PubMed ID: 21508921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
    Schnyder JL; de Jong HK; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2022; 49():102365. PubMed ID: 35661741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions.
    Simons R; Valk PJ; Krul AJ
    J Travel Med; 2005; 12(4):210-6. PubMed ID: 16086896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.